Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in Inflammatory Cardiomyopathy (HYPIC)
NCT05961202Phase 3Recruiting
- Sponsor
- Tongji Hospital
- Start
- Nov 2021
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in inflammatory cardiomyopathy, sponsored by Tongji Hospital. Started Nov 2021; status: recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
inflammatory cardiomyopathy
Beyond the preview
Go deeper on NCT05961202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05961202.